Condition (MeSH)
Embolism, Amniotic Fluid
ClinicalTrials.gov lists 4 trials for Embolism, Amniotic Fluid or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Embolism, Amniotic Fluid itself; the rest are tagged with a narrower condition beneath it.
When did Embolism, Amniotic Fluid trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 1 |
| 2022 | 1 |
| 2021 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 4 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Embolism, Amniotic Fluid trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 1 |
| Observational | 3 |
How many Embolism, Amniotic Fluid trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Completed | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Embolism, Amniotic Fluid? (5)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Acute obstetric coagulopathy during postpartum hemorrhage is caused by hyperfibrinolysis and dysfibrinogenemia: an observational cohort study. | Journal of thrombosis and haemostasis : JTH | 2023 | Yes |
| Pregnancy-related deaths due to pulmonary embolism in Sweden. | Acta obstetricia et gynecologica Scandinavica | 2007 | Yes |
| CMACE 2006-2008. | International journal of obstetric anesthesia | 2011 | No |
| Amniotic fluid removal during cell salvage in the cesarean section patient. | Anesthesiology | 2000 | No |
| Report on confidential enquiries into maternal deaths in England and Wales 1973-1975. | Reports on health and social subjects | 1979 | No |
Prevalence (2)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Amniotic fluid embolism | Point prevalence | Unknown | United Kingdom | GB | Exact |
| Amniotic fluid embolism | Point prevalence | Unknown | United Kingdom | GB | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Amniotic fluid embolism | 617304 | Exact | Orphadata Science knowledge files, Product 1 |
| Amniotic fluid embolism | 617304 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.